Braftovi
| Braftovi | |
|---|---|
| Term | Braftovi |
| Short definition | Braftovi - (pronounced) (braf-TOH-vee) A drug used with cetuximab to treat certain types of colon cancer and with binimetinib to treat certain types of melanoma. It is used in patients whose cancer has a specific mutation (change). |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Braftovi - (pronounced) (braf-TOH-vee) A drug used with cetuximab to treat certain types of colon cancer and with binimetinib to treat certain types of melanoma. It is used in patients whose cancer has a specific mutation (change). BRAFGen. It is also being studied in the treatment of other types of cancer. Braftovi blocks certain proteins made by the mutantsBRAFGene that can help stop cancer cells from growing. It's a kind of kinase inhibitor. Also called encorafenib
External links
- Medical encyclopedia article on Braftovi
- Wikipedia's article - Braftovi
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski